Breast cancer is one of the most serious malignancies among women, accounting for about
12% of all cancers. The inherent complexity and heterogeneity of breast cancer results in …

Simple Summary Risk stratification for early breast cancer (BC) is extremely relevant for
tailoring clinical decisions but challenging due to the absence of comprehensive guidelines …

Invasive ductal carcinoma (IDC) is the most common histological subtype of malignant
breast cancer (BC), and accounts for 70–80% of all invasive BCs. IDC demonstrates great …

Breast cancer is the second leading cause of cancer-related death in women in the world,
and its management includes a combination of surgery, radiation therapy, chemotherapy …

Breast cancer (BC), one of the most common and life-threatening cancers, has the highest
incidence rate among women. Early diagnosis of BC oncomarkers is considered the most …

Metastasis is a serious and often life-threatening condition, representing the leading cause
of death among women with breast cancer (BC). Although the current clinical classification …

Background Invasive ductal carcinoma (IDC) is the most common form of breast cancer
which accounts for 85% of all breast cancer diagnoses. Non-invasive and early stages have …

Cancer is a genetic and complex disorder, resulting from several events associated with
onset, development, and metastasis. Tumor suppressors and oncogenes are among the …

Abstract G0/G1 switch gene 2 (G0S2) is known to inhibit lipolysis by inhibiting adipose
triglyceride lipase (ATGL). In this report, we dissect the role of G0S2 in ER+ versus ER …

The early diagnosis of cancer is vital for effective treatment and improved prognosis. Tumor
biomarkers, which can be used for the early diagnosis, treatment, and prognostic evaluation …